FDA Approves Orserdu and Expands Approval of Trodelvy®
On January 27, 2023, the FDA approved elacestrant (OrserduTM, Stemline Therapeutics, Inc.) and a companion diagnostic test for the treatment of people with...
Read More PAST ARTICLES
2021
- Metastatic Breast Cancer News from 2021 ESMO
- Metastatic Breast Cancer News from ASCO 2021
- Update on Oral SERDs for Estrogen Receptor-Positive MBC
- MBC News from 2021 AACR Meeting
- St. Gallen International Breast Cancer Conference 2021
- The Latest Research on Hormone Receptor-Positive (HR+) MBC
- What is Next-Generation Sequencing?
- Lines of Therapy: New Drugs May Change MBC Treatment
SEARCH OUR SITE
for past articles or specific information.